Executive Management

Gregory J. Sam
Vice President Corporate Quality

Mr. Sam joined Millipore in March 2003 as Vice President of Corporate Quality. Mr. Sam came to Millipore from Elan Corporation, where he was Vice President of Quality for the Drug Delivery Business Unit. Prior To Elan Corporation, Greg Sam was Vice President of Quality at Dura Pharmaceuticals. Mr. Sam also served in quality positions at Watson Laboratories, Rhone-Poulenc Rorer, Wyeth-Ayerst International and Ortho Diagnostic Systems.

Earlier in his career, Greg Sam was a research scientist at Ortho Diagnostic Systems, E.I. Dupont De Nemours and Company, and the National Foundation for Cancer Research.

Mr. Sam holds a B.S. degree in biology from Pennsylvania State University.

IR Contact

Contact for shareholders, potential investors and financial media.

Joshua S. Young
Director, Investor Relations
Tel: 978-715-1527
Joshua_Young@millipore.com

Millipore Contact Information

IR Services

Safe Harbor Statement

The information on the Millipore investor relations website, as well as in future oral and written statements by management of Millipore Corporation that are forward-looking statements, are based on current management expectations that involve substantial risks and uncertainties which could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements.

» More